Yahoo · Oct 23, 2026
Strata Critical Medical and 3 More Stocks See Action From Activist Investors
Activists also report to the SEC on Crescent Energy, Talos Energy, and Navigator Holdings.
SR
NASDAQ · SRTA
Strata Critical Medical, Inc.
Industrials · Airlines, Airports & Air Services
$4.44
Down-$0.31 (-6.53%)
Updated Nov 2, 2026, 12:18 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 454.25M
- P/E ratio
- 10.74
- Dividend yield
- 0.00%
- 52-week range
- $3.95 – $6.50
- Volume
- 1.11M
- Avg. volume
- 907.57K
Price performance · SRTA
SRTA price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
SRTA closed at $4.44 after 20 trading sessions, down 7.69% for the selected period.
- Last close
- $4.44
- Period change
- -7.69%
- Period low
- $4.28
- Period high
- $4.81
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $4.70 | $4.725 | $4.40 | $4.44 | 1.11M |
| Oct 29, 2026 | $4.78 | $4.875 | $4.73 | $4.75 | 1.25M |
| Oct 28, 2026 | $4.73 | $4.78 | $4.66 | $4.76 | 950.59K |
| Oct 27, 2026 | $4.77 | $4.8585 | $4.71 | $4.72 | 911.45K |
| Oct 26, 2026 | $4.67 | $4.81 | $4.62 | $4.76 | 460.51K |
| Oct 23, 2026 | $4.67 | $4.68 | $4.53 | $4.66 | 450.36K |
| Oct 22, 2026 | $4.69 | $4.78 | $4.66 | $4.71 | 688.25K |
| Oct 21, 2026 | $4.70 | $4.79 | $4.65 | $4.73 | 724.52K |
| Oct 20, 2026 | $4.56 | $4.70 | $4.54 | $4.69 | 580.73K |
| Oct 19, 2026 | $4.56 | $4.60 | $4.46 | $4.54 | 1.44M |
| Oct 16, 2026 | $4.55 | $4.70 | $4.50 | $4.54 | 1.58M |
| Oct 15, 2026 | $4.29 | $4.38 | $4.21 | $4.34 | 925.91K |
| Oct 14, 2026 | $4.44 | $4.44 | $4.26 | $4.28 | 825.05K |
| Oct 13, 2026 | $4.53 | $4.58 | $4.45 | $4.45 | 533.68K |
| Oct 12, 2026 | $4.52 | $4.59 | $4.445 | $4.54 | 776.12K |
| Oct 9, 2026 | $4.47 | $4.58 | $4.40 | $4.53 | 623.11K |
| Oct 8, 2026 | $4.65 | $4.65 | $4.455 | $4.47 | 1.14M |
| Oct 7, 2026 | $4.74 | $4.74 | $4.65 | $4.68 | 703.94K |
| Oct 6, 2026 | $4.84 | $4.855 | $4.72 | $4.75 | 760.51K |
| Oct 5, 2026 | $4.76 | $4.91 | $4.685 | $4.81 | 1.16M |
Latest SRTA news
The latest Smart Investors Daily articles mentioning SRTA.
Stock researchCompany · Overview
Company
Market Activity
Research & News
SRTA research
Overview
Company profile and research snapshot.
Company profile
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $7.25
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 25, 2026 | B. Riley Securities | Buy | — |
| Mar 25, 2026 | Craig-Hallum | Buy | — |
| Sep 17, 2025 | Lake Street | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 23, 2026
Strata Critical Medical Schedules Third Quarter 2026 Earnings Conference Call
NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the third quarter ended September 30, 2026 on Tuesday, November 3, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-Chief Executive Offic
Benzinga · Oct 15, 2026
Third Point's Daniel Loeb Urges Strata Critical Medical To Explore Strategic Alternatives Including Potential Sale
The Reporting Persons acquired the securities reported herein for investment purposes and believe that the Common Stock is undervalued. The Reporting Persons believe that the underlying business of the Issuer is strong,
Benzinga · Oct 15, 2026
Strata Critical Medical 13D Filing Shows Third Point Reports 5.8% Stake In Co. As Of Oct. 13
https://www.sec.gov/Archives/edgar/data/1040273/000089914026001108/xslSCHEDULE_13D_X02/primary_doc.xml
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
